HLA-A*0201 CMV pp65 Tetramer-NLVPMVATV-APC

MBL Life Sciences

Catalog No.: MBL-TS-0010-2C

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

• Application: FC
• Reactivity: Human
• Conjugation: APC
• Peptide Sequence: NLVPMVATV
• Class: Class I
• Sequence Location: 495-503
• MHC Allele: A*02:01

Citations for HLA-A*0201 CMV pp65 Tetramer-NLVPMVATV-APC – 2 Found

Sabouri, Amir H; Usuku, Koichiro; Hayashi, Daisuke; Izumo, Shuji; Ohara, Yoshiro; Osame, Mitsuhiro; Saito, Mineki. Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease. Blood. 2008;112(6):2411-20. 

Watanabe, Kazue; Suzuki, Susumu; Kamei, Michi; Toji, Shingo; Kawase, Takakazu; Takahashi, Toshitada; Kuzushima, Kiyotaka; Akatsuka, Yoshiki. CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy. International Journal Of Hematology. 2008;88(3):311-320.